SEC Form 4 · accession 0001213900-17-002655
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gus D Halas
Director
Period of report
Mar 20, 2017
Accepted (ET)
Mar 21, 2017 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001448431
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 20, 2017 | P | 5,000 | $0.77 | A | 74,279 | D | |
| Common Stock | Mar 21, 2017 | P | 16,990 | $0.77 | A | 91,269 | D |
Table II — derivative securities
No Table II lines on this filing.